🟢 Tvardi Therapeutics is trading 5.3% up on October 27, 2026 — no clear catalyst identified

Tvardi Therapeutics is trading at $0.89, up 5.30%, with no clear company-specific catalyst identified for the October 27 move.

• The latest company release located was an October 14 conference participation announcement.
• Tvardi Therapeutics also had a reported +10.37% after-hours move on October 26, with no clear company-specific explanation identified.
• Available information does not establish a catalyst for the current gain.